“The Trump administration intends to end a subsidy program that helped lower costs for Medicare drug plans, a move that could potentially raise monthly costs for older adults,” Bloomberg reports.“At issue are billions in subsidies intended to help control premiums for Medicare Part D coverage, which helps seniors pay for prescription drugs.”